COPE Study: COVID-19 in Older PEople [COVID-19]
Research type
Research Study
Full title
COPE Study: COVID-19 in Older PEople - the influence of frailty and multimorbidity on survival. A multicentre, international observational study.
IRAS ID
281951
Contact name
Jonathan Hewitt
Contact email
Sponsor organisation
Cardiff University
Duration of Study in the UK
0 years, 9 months, 13 days
Research summary
The study aim is to assess frailty and multi-morbidity in older patients admitted to hospital with a diagnosis of COVID -19. Also to correlate frailty with both short term and long-term outcomes. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 or COVID-19) was identified in 2019 as a new strain of pneumonia inducing virus. However COVID-19 has now been declared as a current worldwide pandemic with symptoms including: fever, cough, pneumonia. The majority of people with COVID-19 have mild symptoms (81%), some will develop severe illness requiring oxygen therapy (14%) with few requiring mechanical ventilation (5%). The most common severe diagnosis in COVID-19 patients is severe pneumonia. Study setting: hospitals in the UK (for the purposes of this ethics application) and Worldwide partners (who will require separate local ethical compliance) that provide emergency care for patients diagnosed with COVID-19 have been invited to participate. OPSOC is an established research collaborative, predominantly focusing in surgery in the older person. It is has an international reputation, specifically in the frail older person. Using their experience in collaborative research and frailty, we wish to build on that experience and use that network to consider the frail patient exposed to COVID-19.
REC name
N/A
REC reference
N/A